Glycated Albumin Combined With Body Composition for Gestational Diabetes Mellitus Prediction

NCT04550806 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-10-20

No results posted yet for this study

Summary

This study is going to investigate the predictive ability of glycated albumin combined with body composition, including body weight, BMI, fat free mass and fat mass for gestational diabetes mellitus (GDM) diagnosis.

Conditions

  • Gestational Diabetes Mellitus in Pregnancy

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Kang Yu, MD · Clinical nutrition department of Peking Union Medical College Hospital

Eligibility

Min Age
22 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-06-01
Completion
2021-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04550806 on ClinicalTrials.gov